Abbisko Cayman unit completes first patient dosing in Phase I ABSK211
Abbisko Cayman says its unit has completed first patient dosing in its Phase I trial of ABSK211.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.